---
title: On-Demand Webinar - Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift
description: On-Demand Webinar - Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![Nanotemper Landing Page Banner 07.11.23](https://info.edifydigitalmedia.com/hs-fs/hubfs/Nanotemper%20Landing%20Page%20Banner%2007.11.23.jpg?width=1425&height=400&name=Nanotemper%20Landing%20Page%20Banner%2007.11.23.jpg "Nanotemper Landing Page Banner 07.11.23")

# On-Demand Webinar

# Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift

 

![NanoTemper 11-7-23 CMP asset cover](https://info.edifydigitalmedia.com/hubfs/NanoTemper%2011-7-23%20CMP%20asset%20cover.png "NanoTemper 11-7-23 CMP asset cover")

As more and more R&D pipelines include PROTAC candidates — the race to bring successful and efficient protein degraders to the clinic is on. These targets present challenges in the biophysical characterisation of binary and ternary complexes, making developing effective degraders complicated.

Watch this on-demand webinar to learn:

- How Spectral Shift technology lets you take measurements in-solution and immobilisation free
- What the data from a Spectral Shift experiment characterising protein degraders looks like
- How to save time and sample by reducing the need for complex assay development when working with binary and ternary interactions

  *Brought to you by* 

![NanoTemper-logo-stacked ](https://info.edifydigitalmedia.com/hs-fs/hubfs/NanoTemper-logo-stacked%20.png?width=133&height=34&name=NanoTemper-logo-stacked%20.png)

 

### Download the Webinar

## Copyright 2023 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions